BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Trichostatin A
,
rs4950928
,
PBX1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Waldenström macroglobulinemia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
WM2
WM1
MYD88
IGLJ3
DDX3Y
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
PUJANA_BRCA1_PCC_NETWORK
RNA binding
nucleoplasm
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
CD57-negative and positive cytotoxic T-cells from Waldenstrom's Macroglobulinaemia patients
Bone marrow of chromosome 6q deletion subjects with Waldenstrom's macroglobulinemia
B lymphocytes from Waldenstrom’s macroglobulinemia and IgM monoclonal gammopathy (MGUS) patients
Waldenstrom macroglobulinemia BCWM.1 cells expressing mutant CXCR4 (C1013G)
Plasma cells and B cells from Waldenström’s macroglobulinemia, multiple myeloma, and CLL
Explore Curated Studies Results
Literature
Most Relevant Literature
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for…
Waldenström Macroglobulinemia: Targeted Agents Taking Center Stage.
Optimizing BTK Inhibition in Waldenström Macroglobulinemia.
Diagnosis and Risk Stratification in Waldenström Macroglobulinemia.
Future Directions in the Frontline Management of Waldenström Macroglobulinemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
Dasatinib In Waldenström Macroglobulinemia
Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia
Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ